D. Boral Capital Reaffirms Buy Rating for CorMedix (NASDAQ:CRMD)
CorMedix (NASDAQ:CRMD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. D. Boral Capital’s price target would suggest a potential downside of 4.58% from the company’s current price. Several other […]
CorMedix (NASDAQ:CRMD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a report released on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. D. Boral Capital’s price target would suggest a potential downside of 4.58% from the company’s current price. Several other […]
